Literature DB >> 19274670

Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma.

Vincenzo Ambrogi1, Davide Mineo, Antonio Gatti, Eugenio Pompeo, Tommaso C Mineo.   

Abstract

BACKGROUND: Extrapleural pneumonectomy for malignant pleural mesothelioma is considered an aggressive procedure, but symptomatic and quality of life changes are unknown.
METHODS: Between 1997 and 2004, 16 consecutive patients underwent extrapleural pneumonectomy for mesothelioma followed by chemo-radiotherapy. Tumor-related symptoms and quality of life (Short-Form-36 and St. George's questionnaires) were assessed pre, 3, 6, 12, and 24 months postoperatively.
RESULTS: Thirty-day postoperative major morbidity was 31% with no mortality. At 3 months postoperatively, dyspnea improved in 10 patients (62%), pain in 12 (75%), cough in 10 (62%), fever in 11 (68%), Karnofsky-index in 10 (62%), Short-Form-36 physical-component-summary in 8, mental-component-summary in 5 and total St. George score in 8 (50%). At 1 year 10 (62%) patients were alive and majority of improved parameters were still stable. Thereafter they usually started to decline. Survival was influenced by nonepithelial histology (P < 0.01) and N2-disease (P < 0.01), which showed to be the only prognosticator at Cox regression (P < 0.0001, Odd ratio 5.4). Among symptomatic variables, a 3-month postoperative Short-Form-36 physical-component-summary above the median value correlated significantly with a better prognosis (P < 0.02).
CONCLUSIONS: Extrapleural pneumonectomy may rapidly improve symptoms as well as quality of life, especially in physical domains. Other than biological factors, postoperative Short-Form-36 physical component as well, significantly influenced the prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19274670     DOI: 10.1002/jso.21261

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  The impact of surgical approach on quality of life for pleural malignant mesothelioma.

Authors:  Rebecca M Schwartz; Alexis Watson; Andrea Wolf; Raja Flores; Emanuela Taioli
Journal:  Ann Transl Med       Date:  2017-06

Review 2.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

Review 3.  Management of malignant pleural mesothelioma-The European experience.

Authors:  Isabelle Opitz
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

4.  Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Yusuke Itani; Satoshi Mabuchi; Norihiko Kodama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2017-03-14       Impact factor: 3.603

5.  Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Toru Nakamichi; Yuki Uchiyama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2019-02-20       Impact factor: 3.603

Review 6.  [Malignant pleural mesothelioma: comparison of radical pleurectomy und extrapleural pneumonectomy].

Authors:  S Bölükbas; J Schirren
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

Review 7.  Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).

Authors:  Loretta A Williams; Meagan S Whisenant; Tito R Mendoza; Shireen Haq; Karen N Keating; Brian Cuffel; Charles S Cleeland
Journal:  Qual Life Res       Date:  2018-09-05       Impact factor: 4.147

8.  Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Rebecca M Schwartz; Wil Lieberman-Cribbin; Andrea Wolf; Raja M Flores; Emanuela Taioli
Journal:  BMC Cancer       Date:  2018-11-29       Impact factor: 4.430

9.  The use of patient-reported outcome measures (PROMs) in the management of malignant pleural mesothelioma: a descriptive literature survey.

Authors:  Youssef Ben Bouazza; Jan P Van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2018-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.